Newsroom

Sorted by: Latest

-

Pure Barre Launches Student Unlimited Membership

IRVINE, Calif.--(BUSINESS WIRE)--Pure Barre, the leading Barre boutique fitness studio, is offering students a third space in the midst of busy schedules with its new Student Unlimited Membership. The pricing structure lets students access barre's mental and physical benefits without breaking their budget. Monthly pricing ranges from $99 to $249. "The past couple of years, Pure Barre has been a consistent part of my routine," says Pure Barre Pittsburgh member, Kasey Sipos. "I’m in a doctorate p...
-

Riassunto: Un nuovo trial sulle lenti a contatto Visioneering Technologies mostra risultati storici nel rallentare la miopia nei bambini

ANAHEIM, Calif.--(BUSINESS WIRE)--Visioneering Technologies, Inc. (VTI), un produttore di dispositivi medici che progetta e commercializza lenti a contatto speciali, presenterà i risultati completi della sperimentazione clinica triennale PROTECT – uno studio prospettico, in doppio cieco, multinazionale, controllato e randomizzato che ha valutato le lenti a contatto NaturalVue® (etafilcon A) Multifocal 1 Day riguardo al rallentamento della progressione della miopia nei bambini. Ashley Tuan, OD,...
-

Une nouvelle étude clinique menée par Visioneering Technologies sur des lentilles de contact révèle des résultats historiques dans le ralentissement de la myopie chez les enfants

ANAHEIM, Calif.--(BUSINESS WIRE)--Visioneering Technologies, Inc. (VTI), une société de dispositifs médicaux qui conçoit et commercialise des lentilles de contact spécialisées, va annoncer les résultats complets de l’étude PROTECT, un essai prospectif, en double aveugle, multinational, randomisé et contrôlé, d’une durée de trois ans, évaluant l’efficacité des lentilles de contact NaturalVue® (étafilcon A) Multifocal 1 Day de la société pour ralentir la progression de la myopie chez les enfants....
-

Resumen: El nuevo ensayo con lentes de contacto de Visioneering Technologies arroja resultados históricos en la ralentización de la miopía infantil

ANAHEIM, Calif.--(BUSINESS WIRE)--Visioneering Technologies, Inc. (VTI), una empresa de dispositivos médicos dedicada al diseño y la comercialización de lentes de contacto especializadas, anunciará los resultados completos a tres años del estudio PROTECT, un ensayo clínico prospectivo, doble ciego, multinacional, aleatorizado y controlado, en el que se evalúa la lente de contacto multifocal de un día NaturalVue® (etafilcon A) de la empresa para ralentizar la progresión de la miopía en niños. As...
-

NATIXIS UK Regulatory Announcement: Form 8.3 Prologis, Inc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...
-

BostonGene Chief Medical Officer to Discuss Biologically Grounded AI and Multimodal Data in Oncology Drug Development at the 2nd Annual Global Cancer Research & Innovation Symposium

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI model for tumor and immune biology, today announced that Nathan Fowler, MD, Chief Medical Officer, will participate in the 2nd Annual Global Cancer Research & Innovation Symposium, taking place October 5–6, 2026, in New York City. Dr. Fowler will join leaders from across the oncology ecosystem for a discussion on how multimodal data can be integrated to improve drug discovery and clinical development. As oncology thera...
-

MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced the appointment of Kim Remizowski to its Board of Directors as an independent director, effective September 29, 2026. Mr. Remizowski will serve on the Audit Committee and the Compensation, Nomination and Governance Committee. The Board has determined that he qualifies as an independent director under Nasdaq listing rules and as an audit committee financial expert under a...
-

SABA Announces $0.058 Dividend

NEW YORK--(BUSINESS WIRE)--Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, declared a monthly dividend of $0.058 per share on September 30, 2026, payable on October 30, 2026 to shareholders of record as of October 9, 2026. Managed Distribution Plan. The above distribution was declared in accordance with the Fund’s currently effective managed distribution plan (the “Plan”), whe...
-

BRW Announces $0.085 Dividend

NEW YORK--(BUSINESS WIRE)--Saba Capital Income & Opportunities Fund (NYSE: BRW) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, declared a monthly dividend of $0.085 per share on September 30, 2026, payable on October 30, 2026 to shareholders of record as of October 9, 2026. Managed Distribution Plan. The above distribution was declared in accordance with the Fund’s currently effective managed distribution plan (the “Plan”), whereby...
-

Samenvatting: Carrier en PHINIA onderscheiden met ISG Paragon Awards North America 2026 voor transformatie geleverd met LTM

MUMBAI, India--(BUSINESS WIRE)--LTM, de 'Business Creativity'-partner van de grootste ondernemingen ter wereld, maakte vandaag bekend dat zijn klanten PHINIA en Carrier bekroond werden op de ISG Paragon Awards North America 2026. LTM ontving erkenning in de categorie Excellence voor zijn werk met PHINIA en in de categorie Transformation voor zijn werk met Carrier. De ISG Paragon Awards zijn onderscheidingen voor samenwerkingsverbanden tussen bedrijven en leveranciers die technologie, innovatie...